Diagnosing Change: Celera Genomics' Strategic Drug Sell-Off
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 74 (Table of Contents)
Published: 1 Aug-2006
DOI: 10.3833/pdr.v2006.i74.474 ISSN: 1756-7874
Section: Features
Fulltext:
Abstract
Founded by Applera in 1998 and tasked with sequencing the human genome, Celera Genomics has since expanded its commercial portfolio substantially, diversifying into both drug discovery and diagnostics via the creation, in 2002, of Celera Diagnostics, a joint venture with Applied Biosystems; all three companies operated under the umbrella of parent company Applera...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS